Literature DB >> 19732613

Disorders of placental circulation and the fetal brain.

Raymond W Redline1.   

Abstract

Disorders of the placental circulation, including the release of deleterious mediators to the fetus, are important risk factors for central nervous system complications. These disorders result in discrete patterns of placental injury detectable by a thorough placental pathologic examination. Consideration of the location, severity, multiplicity, and timing of these lesions is critical to a full understanding of their significance. Less than 10% of placentas from term infants that later develop cerebral palsy lack any evidence of placental abnormalities potentially related to adverse outcome.

Entities:  

Mesh:

Year:  2009        PMID: 19732613     DOI: 10.1016/j.clp.2009.06.003

Source DB:  PubMed          Journal:  Clin Perinatol        ISSN: 0095-5108            Impact factor:   3.430


  10 in total

1.  Chorioamnionitis in Rats Precipitates Extended Postnatal Inflammatory Lymphocyte Hyperreactivity.

Authors:  Tracylyn R Yellowhair; Shahani Noor; Brittney Mares; Clement Jose; Jessie C Newville; Jessie R Maxwell; Frances J Northington; Erin D Milligan; Shenandoah Robinson; Lauren L Jantzie
Journal:  Dev Neurosci       Date:  2019-03-28       Impact factor: 2.984

Review 2.  The developmental basis of epigenetic regulation of HTR2A and psychiatric outcomes.

Authors:  Alison G Paquette; Carmen J Marsit
Journal:  J Cell Biochem       Date:  2014-12       Impact factor: 4.429

3.  3-D volumetric MRI evaluation of the placenta in fetuses with complex congenital heart disease.

Authors:  Nickie Andescavage; Alexa Yarish; Mary Donofrio; Dorothy Bulas; Iordanis Evangelou; Gilbert Vezina; Robert McCarter; Adre duPlessis; Catherine Limperopoulos
Journal:  Placenta       Date:  2015-07-06       Impact factor: 3.481

4.  The alarmin S100A12 causes sterile inflammation of the human chorioamniotic membranes as well as preterm birth and neonatal mortality in mice†.

Authors:  Kenichiro Motomura; Roberto Romero; Olesya Plazyo; Valeria Garcia-Flores; Meyer Gershater; Jose Galaz; Derek Miller; Nardhy Gomez-Lopez
Journal:  Biol Reprod       Date:  2021-12-20       Impact factor: 4.161

5.  Socioeconomic disadvantage and neural development from infancy through early childhood.

Authors:  Galen Chin-Lun Hung; Jill Hahn; Bibi Alamiri; Stephen L Buka; Jill M Goldstein; Nan Laird; Charles A Nelson; Jordan W Smoller; Stephen E Gilman
Journal:  Int J Epidemiol       Date:  2015-12-16       Impact factor: 7.196

6.  Repetitive Neonatal Erythropoietin and Melatonin Combinatorial Treatment Provides Sustained Repair of Functional Deficits in a Rat Model of Cerebral Palsy.

Authors:  Lauren L Jantzie; Akosua Y Oppong; Fatu S Conteh; Tracylyn R Yellowhair; Joshua Kim; Gabrielle Fink; Adam R Wolin; Frances J Northington; Shenandoah Robinson
Journal:  Front Neurol       Date:  2018-04-13       Impact factor: 4.003

7.  Cortical cells are altered by factors including bone morphogenetic protein released from a placental barrier model under altered oxygenation.

Authors:  Veronica H L Leinster; Thomas J Phillips; Nicola Jones; Sharon Sanderson; Katja Simon; Jon Hanley; Charles Patrick Case
Journal:  Neuronal Signal       Date:  2020-04-09

Review 8.  Optimal management of umbilical cord prolapse.

Authors:  Waleed Ali Sayed Ahmed; Mostafa Ahmed Hamdy
Journal:  Int J Womens Health       Date:  2018-08-21

9.  Sustained peripheral immune hyper-reactivity (SPIHR): an enduring biomarker of altered inflammatory responses in adult rats after perinatal brain injury.

Authors:  Yuma Kitase; Eric M Chin; Sindhu Ramachandra; Christopher Burkhardt; Nethra K Madurai; Colleen Lenz; Alexander H Hoon; Shenandoah Robinson; Lauren L Jantzie
Journal:  J Neuroinflammation       Date:  2021-10-19       Impact factor: 8.322

10.  PSB0788 ameliorates maternal inflammation-induced periventricular leukomalacia-like injury.

Authors:  Yilu Li; Dan Wang; Zhuoyang Li; Zhi Ouyang
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.